CBSCBS News·2hHealth
score+0.15
FDA panel considers loosening regulations on certain unapproved peptides
Original
FDA panel considers loosening regulations on certain unapproved peptides
“Neutral regulatory language with mild positive framing ('broadening access') but omits safety implications and stakeholder concerns.”